BAEP screening for the prediction of tardive dyskinesia in schizophrenia.
Coger
R W
RW
Bartzokis
G
G
Serafetinides
E A
EA
D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001933:Brain Stem / Q000187:drug effects* / Q000503:physiopathology; D004409:Dyskinesia, Drug-Induced / Q000503:physiopathology*; D005072:Evoked Potentials, Auditory / Q000187:drug effects*; D006801:Humans; D009474:Neurons / Q000502:physiology; D012307:Risk Factors; D012559:Schizophrenia / Q000188:drug therapy*
D014150:Antipsychotic Agents